Articles (33) Publications in which a researcher has participated View referenced research data.

in the year 2024 Remove filter
filter_list Type (aggr.) Articles from 2024 to 2024

2024

  1. A Missense Variant in TP53 Could Be a Genetic Biomarker Associated with Bone Tissue Alterations

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  2. A Synergistic Approach Therapy for Colorectal Cancer Based on Exosomes and Exploitation of Metabolic Pathways

    Journal of Pharmaceutical Sciences, Vol. 113, Núm. 4, pp. 1038-1046

  3. A lactate-dependent shift of glycolysis mediates synaptic and cognitive processes in male mice

    Nature Communications, Vol. 15, Núm. 1

  4. A proteomic approach supports the clinical relevance of TAT-Cx43266-283 in glioblastoma

    Translational Research, Vol. 272, pp. 95-110

  5. Career pathways, part 15

    Nature Metabolism, Vol. 6, Núm. 10, pp. 1842-1845

  6. Combined HRAS and NRAS ablation induces a RASopathy phenotype in mice

    Cell Communication and Signaling, Vol. 22, Núm. 1

  7. Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition

    Nature Communications , Vol. 15, Núm. 1

  8. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266–283 antitumor response in preclinical glioblastoma models

    Neuro-Oncology, Vol. 26, Núm. 7, pp. 1230-1246

  9. Evolution of Fentanyl Prescription Patterns and Administration Routes in Primary Care in Salamanca, Spain: A Comprehensive Analysis from 2011 to 2022

    Healthcare (Switzerland), Vol. 12, Núm. 16

  10. Exposure of Zebrafish Embryos to Morphine and Cocaine Induces Changes in the Levels of Dopamine and of Proteins Related to the Reward Pathway

    Fishes, Vol. 9, Núm. 7

  11. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy

    CANCER DRUG RESISTANCE, Vol. 7

  12. Impact of liver diseases and pharmacological interactions on the transportome involved in hepatic drug disposition

    Biochemical Pharmacology, Vol. 228

  13. Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma

    Cancer Cell International, Vol. 24, Núm. 1

  14. Muscle Hypertrophy Is Linked to Changes in the Oxidative and Proteolytic Systems during Early Tenderization of the Spanish Breed “Asturiana de los Valles”

    Foods, Vol. 13, Núm. 3

  15. Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer

    Nutrients, Vol. 16, Núm. 15

  16. Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer

    Oncogenesis, Vol. 13, Núm. 1

  17. Potent, selective and reversible hMAO-B inhibition by benzalphthalides: Synthesis, enzymatic and cellular evaluations and virtual docking and predictive studies

    Bioorganic Chemistry, Vol. 146

  18. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

  19. Pursuing precision in medicine and nutrition: the rise of electrochemical biosensing at the molecular level

    Analytical and Bioanalytical Chemistry, Vol. 416, Núm. 9, pp. 2151-2172

  20. Relationship between cholestasis and altered progesterone metabolism in the placenta-maternal liver tandem

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 2